CA
CMPX icon

CHI Advisors’s Compass Therapeutics CMPX Stock Holding History

CHI Advisors’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$5.57M Hold
2,829,712
– – 2.21% 10
2023
Q2 		$9M Hold
2,829,712
– – 2.73% 8
2023
Q1 		$9.25M Hold
2,829,712
– – 2.46% 8
2022
Q4 		$14.2M Hold
2,829,712
– – 3.79% 7
2022
Q3 		$6.45M Hold
2,829,712
– – 1.73% 11
2022
Q2 		$7.5M Hold
2,829,712
– – 2.86% 9
2022
Q1 		$3.88M Sell
2,829,712
-193,980
-6% -$401K 1.65% 14
2021
Q4 		$9.59M Buy
+3,023,692
New +$10M 3.18% 10

Other funds holding CMPX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

CHI Advisors's CMPX Position: Q3 2023 in Review

CHI Advisors held its Compass Therapeutics (CMPX) position steady in Q3 2023 at 2,829,712 shares worth $5.57M. The position accounts for 2.21% of the portfolio, ranked #10.

CHI Advisors first reported a position in CMPX in Q4 2021 and has held it in 8 quarters since. The position peaked at $14.2M in Q4 2022. 76 funds tracked by Wall St. Rank hold CMPX as of Q3 2023.

  • CHI Advisors held 2,829,712 shares of Compass Therapeutics worth $5.57M as of Q3 2023.
  • CHI Advisors left its Compass Therapeutics share count unchanged in Q3 2023.
  • Compass Therapeutics made up 2.21% of CHI Advisors's portfolio in Q3 2023, its #10 holding.
  • CHI Advisors first reported a position in Compass Therapeutics in Q4 2021 and has held it in 8 quarters since.
  • CHI Advisors's Compass Therapeutics position peaked at $14.2M in Q4 2022.
  • 76 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.